Nursing home antipsychotic legislation set aside

Share this article:
Nursing home antipsychotic legislation set aside
Nursing home antipsychotic legislation set aside

The U.S. Senate did not approve legislation that would strengthen regulations for antipsychotic use in nursing homes, despite overwhelmingly passing a bill it was attached to on Thursday.

Last week, Sens. Herb Kohl (D-WI), Charles Grassley (R-IA) and Richard Blumenthal (D-CT) proposed a regulation that would have standardized protocols for obtaining informed consent before administering antipsychotics for off-label use. The legislation was proposed as an amendment to an existing Food and Drug Administration reauthorization bill (S. 3187), which was passed by the Senate in a 96-1 vote Thursday.

However, a spokesman for the Special Senate Committee on Aging told McKnight's that the nursing home regulation was not voted on and wasn't included in the manager's amendment.

He added that “the amendment was filed to help bring some needed attention to the widespread problem of the misuse of the antipsychotics among frail elders.” Going forward, he said Kohl and Grassley will “look at other legislative vehicles or stand-alone legislation.”

Senate Majority Leader Harry Reid (D-NV) had urged quick passage of the bill, without many amendments. Senators agreed to consider just 17 of them.

Share this article:

More in News

Skilled nursing facilities with poor quality ratings do not readmit more patients to hospitals, researchers find

Skilled nursing facilities with poor quality ratings do ...

Low-quality and high-quality skilled nursing facilities readmit about the same proportion of residents to hospitals, suggest research findings recently published in the American Journal of Medical Quality.

Cipro and related antibiotics increase MRSA risk in long-term care facilities, study ...

Long-term care residents on a fluoroquinolone antibiotic such as Cipro are at an increased risk for methicillin-resistant Staphylococcus aureus, researchers in France have found.

Jonathan Blum, who oversaw long-term care reforms, resigns as head of Medicare

The nation's top Medicare official, Jonathan Blum, is leaving his post next month, news outlets reported Tuesday. Blum became a familiar figure to long-term care providers through Open Door Forum calls and other outreach efforts during his five-year tenure, as he guided implementation of Medicare ...